SecBot SecBot

SSII

SS Innovations International, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. FL· CIK 0001676163 Healthcare & Medical Devices
$2.37 +0.12 (+5.33%)
Oct 26 4:00 PM ET · prev $2.25
Market cap
$475.2M
Small cap
Median target
$7.00
+195% · range $7.00–7.00
Next earnings
Nov 3
in 8 days · EPS est. −$0.01
1 year
−72.4%
from $8.60 · Oct 27
30 days
−18.0%
from $2.89
52-week range
$2.25–8.65
−73% from high · low Oct 23
Avg volume 20D
60.7K
shares / day
Short interest
67.8K
≈0.0% of shares · +13.6%
Days to cover
1.0
at average volume
Insider net
+$5.1M
3 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
20
analyzed by SecBot
SecBot read BEARISH 8 reports · 90 days
Balance 2 bearish · 0 bullish · 1 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 4/8 ·Next Earnings date, Nov 3, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $5.2M at an average $4.00. 1 insider sold $100.0K. Price is 41% below their cost.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 2 trimmed or exited.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.010 → −$0.010 over 90 days.

  • Short sellersSTEADY

    Short interest +13.6% to 67.8K shares. 1.0 days to cover, ≈0.0% of shares.

  • TrendDOWNTREND

    23% below its 50-day average. New closing low $2.25 on Oct 23.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ROYAL BANK OF CANADATRIM85—
UBS Group AGTRIM51,208$212.5K
UBS Group AGDOUBLED191,156$1.1M
PNC FINANCIAL SERVICES GROUP, INC.ADD13,627$77.4K
GEODE CAPITAL MANAGEMENT, LLCADD30,049$195.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jun 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +195%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Jun 3, 2026LUCID CAPITAL MARKETS
INITIATE
INITIATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 26, 2026
Announcement
🔒 Fresh data, subscribers only
Oct 13, 2026
Press release
SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi Mantra
FORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ:...
Aug 13, 2026
Earnings
SS Innovations Reports Second Quarter 2026 Financial Results
Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in…
Aug 6, 2026
Earnings date
SSII Q2 2026 Earnings Scheduled — 2026-08-06
Aug 4, 2026
Earnings date
SSII Q2 2026 Earnings Scheduled — 2026-08-04

Insider ledger

Form 4
$5.2M
bought · 3 insiders
$100.0K
sold · 1 insider
−40.7%
vs their $4.00 cost
DateInsiderTypeValue
Oct 9, 2026
Sudhir Srivastava
Chairman and CEO
GIFT50,000 sh
Sep 4, 2026
Sudhir Srivastava
Chairman and CEO
SELL$100.0K
Aug 14, 2026
Sudhir Srivastava
Chairman and CEO
GIFT10,000 sh
Jun 4, 2026
Vishwajyoti Pascual Srivastava
CEO - Asia Pacific
GIFT1,000,000 sh
Jun 4, 2026
Sudhir Srivastava
Chairman and CEO
GIFT1,000,000 sh
Jun 1, 2026
Cohen Barry F
COO - Americas
GIFT25,000 sh
May 12, 2026
Sudhir Srivastava
Chairman and CEO
OTHER$107.5K
Apr 14, 2026
Sudhir Srivastava
Chairman and CEO
GIFT10,000 sh

Earnings setup

Estimates
Nov 3
reports in 8 days
−$0.01
EPS estimate, this quarter
0%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.01-$0.01–-$0.01+0.0%$15.1M
Next Q-$0.01-$0.01–-$0.01+0.0%$19.5M
Current FY-$0.06-$0.06–-$0.06+0.0%$59.6M
Next FY-$0.06-$0.06–-$0.06+0.0%$76.2M

Short side

FINRA· Sep 30, 2026
67,764
shares short
+13.6%
vs prior settlement
1.0
days to cover
≈0.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 26, 2026 Press
🔒 Fresh report (last 24h), subscribers only
Oct 26, 2026 Announcement
🔒 Fresh data, subscribers only
Oct 13, 2026 SEC
SS Innovations submitted its response to an FDA request for additional information (AINN) regarding its 510(k)…
8-K — Impact 4/10
Oct 13, 2026 SEC
SS Innovations International issued a $21.025M secured convertible promissory note to Growth Capital Partners, LLC…
8-K — Impact 6/10
Oct 9, 2026 Insider
Sudhir Srivastava gifted 50,000 shares
Chairman and CEO
Sep 4, 2026 Insider
Sudhir Srivastava sold 33,333 shares
Chairman and CEO @ $3.00 ($100.0K)
Aug 14, 2026 Insider
Sudhir Srivastava gifted 10,000 shares
Chairman and CEO

SecBot reports

20 filings · 2 press releases · 1 bullish · 3 bearish · 2 mixed · 14 neutral
All SSII filing & press-release reports (22)